AusPAR: Vyalev

Australian Public Assessment Report

AusPAR

AusPAR: Vyalev [PDF, 1018.03 KB]

AusPAR: Vyalev [Word, 1.11 MB]

Attachment: Product information for Vyalev [PDF, 448.01 KB]

Attachment: Product information for Vyalev [Word, 235.11 KB]

Device/Product Name

Vyalev

Active ingredients

Foslevodopa and Foscarbidopa

AusPAR Date

21 October 2024

Published

14 November 2024

Submission Number

PM-2021-03724-1-1

Submission Type

New fixed dose combination medicine Vyalev, containing 2 new chemical entities (foslevodopa and foscarbidopa)

Decision

Approved